Atrasentan for the treatment of diabetic nephropathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Atrasentan for the treatment of diabetic nephropathy

Published:2017-05-19 Issue:6 Volume:26 Page:741-750
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Egido Jesus¹²³⁴,Rojas-Rivera Jorge¹,Mas Sebastian²³,Ruiz-Ortega Marta²,Sanz Ana Belen²,Gonzalez Parra Emilio¹⁴,Gomez-Guerrero Carmen²³

Affiliation:

1. Division of Nephrology and Hypertension, Madrid, Spain

2. Renal, Vascular and Diabetes Research Laboratory University Hospital Fundacion Jimenez Diaz. Autonoma University (UAM), Madrid, Spain

3. Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid, Spain

4. FRIAT (Fundacion Renal Iñigo Alvarez de Toledo), Madrid, Spain

Funder

FEDER-FIS

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2017.1325872

Reference70 articles.

1. Global Prevalence of Diabetes

2. Standards of Medical Care in Diabetes—2014

3. Therapeutic approaches to diabetic nephropathy—beyond the RAS

4. A novel potent vasoconstrictor peptide produced by vascular endothelial cells

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning application identifies plasma markers for proteinuria in metastatic colorectal cancer patients treated with Bevacizumab;Cancer Chemotherapy and Pharmacology;2024-02-25

2. L- Thyroxine ameliorates renal function in thyroidectomized diabetic nephropathy rats through downregulation of TGF- β1, Ang II and ET-1 expression;Egyptian Journal of Basic and Applied Sciences;2023-09

3. Research progress on the role of ET‐1 in diabetic kidney disease;Journal of Cellular Physiology;2023-04-17

4. Efficacy and safety of drugs for people with type 2 diabetes mellitus and chronic kidney disease on kidney and cardiovascular outcomes: A systematic review and network meta-analysis of randomized controlled trials;Diabetes Research and Clinical Practice;2023-04

5. Novel Aspects of the Immune Response Involved in the Peritoneal Damage in Chronic Kidney Disease Patients under Dialysis;International Journal of Molecular Sciences;2023-03-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3